-
Furyk wants long-term US Ryder blueprint, maybe role for Tiger
-
McIlroy back on course on eve of PGA despite blister
-
France locks down 1,700 on cruise ship after 92-year-old dies
-
Eulalio seizes control of drenched Giro d'Italia
-
New trial ordered for US lawyer convicted of murdering wife, son
-
Stocks rise ahead of US-China summit
-
US wholesale prices jump 6.0% year-on-year in April, highest since 2022
-
Nations drawing down oil stocks at record pace: IEA
-
Carrick on brink of permanent Man Utd job: reports
-
Strong US economy's resilience to shocks tested by Iran war
-
Starmer clings on as leadership talk overshadows king's speech
-
Italy cheers UK's Catherine on first foreign visit since cancer diagnosis
-
Keys says players will strike over Grand Slam pay if 'necessary'
-
Eurovision stage inspired by Viennese opera
-
Gunshots at Philippine Senate as lawmaker wanted by ICC holds out
-
Winning worth the wait for Young no matter the ball
-
The Chilean town living with the world's most polluting dump
-
Donald pleased to have Rahm back for Ryder three-peat bid
-
Stocks waver, oil steady ahead of US-China summit as Iran talks stall
-
War in Middle East: latest developments
-
No cadmium please: French want less toxin in their baguettes
-
Warsh set to take over a divided Fed facing Trump assaults
-
Shots heard at Philippine Senate as lawmaker wanted by ICC holds out
-
France locks down 1,700 on cruise ship after 90-year-old dies
-
After the hobbits, director Peter Jackson tackles 'Tintin'
-
Real Madrid win legal battle over Bernabeu concert noise
-
EU won't ban LGBTQ 'conversion therapy' but will push states to act
-
Revived Swiatek cruises past Pegula and into Italian Open semis
-
Shots heard at Philippine Senate as lawmaker wanted by ICC holds out: AFP
-
Vin Diesel drives 'Fast and Furious' tribute in Cannes
-
Heckler ejected from Eurovision after Israel song disruption
-
Australia's North savours 'tremendous honour' of England role
-
For hantavirus, experts aim to inform without igniting Covid panic
-
Japan rides box office boom into Cannes
-
Trump arrives in China for superpower summit with Xi
-
UK's Catherine on first official foreign trip since cancer diagnosis
-
British scientists among winners of top Spanish award
-
Mbappe can show 'commitment' to Real Madrid: Arbeloa
-
Chinese tech giant Alibaba posts profit drop amid AI drive
-
King Charles lays out Starmer's agenda as PM fights for survival
-
Japan suspend Eddie Jones for verbally abusing officials
-
England drop Crawley for 1st Test against New Zealand
-
Stocks rise ahead of US-China summit as Iran talks stall
-
One trip, one ticket: New EU rules aim to ease train travel
-
SoftBank profit quadruples to $32 bn on AI investments
-
Africa must drop 'victim mentality': mogul Tony Elumelu
-
'Ungovernable' Britain? Once-stable politics in freefall
-
China tech giant Tencent sees Q1 profit jump after AI bets
-
Nissan expects return to profit after huge loss
-
World Cup broadcast deadlock ends up in Indian court
Cervical cancer vaccine push has saved 1.4 million lives: Gavi
A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million cervical cancer deaths, the vaccine alliance Gavi said Monday.
"An estimated 86 million girls are now protected against the leading cause of cervical cancer, thanks to a concerted three-year effort by Gavi, the Vaccine Alliance and lower-income countries," the organisation said.
It added in a statement to mark World Cervical Cancer Elimination Day that "an estimated 1.4 million future deaths" had been prevented.
Cancer caused by HPV disproportionately affects low-income countries, which often lack screening services and access to treatment.
These countries accounted for 90 percent of the 350,000 cervical cancer deaths recorded in 2022, according to Gavi.
The organisation's chief executive Sania Nishtar credited the "incredible commitment" by countries and organisations for helping to reach the target of protecting 86 million girls.
Gavi said that across Africa the coverage rate for the vaccine had risen from four percent of girls in 2014 to 44 percent at the end of 2024, higher than for Europe on 38 percent.
The alliance said it used economies of scale to bring down prices and make vaccines available to about 50 poorer countries.
"Gavi secured commitments from manufacturers to invest in HPV vaccines -– and the price of HPV vaccines in Gavi-supported countries is now between $2.90 and $5.18 per dose, compared with US$100 or more elsewhere," said the statement.
"This collaborative effort is driving major global progress towards eliminating one of the deadliest diseases affecting women," she said, while stressing that the cancer still kills a woman every two minutes.
The World Health Organization (WHO) officially backed a single-dose HPV vaccination schedule instead of the previous two doses in 2022, allowing twice as many girls to be vaccinated with existing stocks.
L.Hussein--SF-PST